Last reviewed · How we verify

NCT07082023: vnotes

Comparison of V-NOTES and Laparoscopic Mesh-Free Sacrocolpopexy Techniques

Recruiting now NA Last updated 24 July 2025
What this trial tests

NA trial testing V-NOTES Mesh-Free Sacrocolpopexy in Pelvic Organ Prolapse in 52 participants. Currently enrolling.

Timeline
1 July 2025
Primary endpoint
1 January 2026
1 January 2026

Quick facts

Lead sponsorHavva Betül Bacak
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment52
Start date1 July 2025
Primary completion1 January 2026
Estimated completion1 January 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Havva Betül Bacak — full company profile →

Who can join

Adults 18 to 75, female only, with Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare the surgical outcomes, safety profiles, and patient satisfaction between two minimally invasive techniques for pelvic organ prolapse repair: Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) mesh-free sacrocolpopexy and laparoscopic mesh-free sacrocolpopexy. By evaluating perioperative data, complication rates, anatomical and functional outcomes, this trial seeks to determine whether the V-NOTES approach provides comparable or superior results to the traditional laparoscopic technique, without the use of synthetic mesh.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pelvic Organ Prolapse

Currently open trials in the same condition.

Other Havva Betül Bacak trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07082023.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing